Tuesday, February 14, 2012
Advertisement

News: February 14, 2012

Popular Diabetes Drug Might Cut Pancreatic Cancer Risk: Study
TUESDAY, Jan. 31 (HealthDay News) -- A new Swiss-American study indicates that long-term use of the popular diabetes medication metformin may lower the risk of developing pancreatic cancer, at least among women. The researchers also found that the...
Blood Test Shows Promise in Spotting Pancreatic Cancers Early
TUESDAY, Jan. 17 (HealthDay News) -- A new blood test may hold promise as a means of early detection and diagnosis for often deadly pancreatic cancers. Reporting Tuesday at the annual Gastrointestinal Cancers Symposium in San Francisco, researcher...
Gene Mutation May Be Key to Familial Pancreatic Cancer
THURSDAY, Dec. 29 (HealthDay News) -- Individuals may face a higher hereditary risk for developing pancreatic cancer if they carry abnormalities in the so-called "ATM" gene, new research reveals. The finding, reported in an upcoming issue of Cance...
Oral Bacteria Might Signal Early Pancreatic Cancer
WEDNESDAY, Oct. 12 (HealthDay News) -- Changes in the bacteria in a person's mouth might signal the onset of pancreatic cancer, preliminary research reveals. The small study suggests that it eventually might be possible to screen for the deadly di...
Pancreatic Cancer: A Stubborn Foe
THURSDAY, Oct. 6 (HealthDay News) -- The death of Apple Inc. co-founder Steve Jobs has once again focused attention on cancers of the pancreas, which have claimed the lives of several high-profile celebrities. Jobs' tumor was actually one with a b...
Popular Diabetes Drugs May Raise Pancreatic Cancer Risk, Study Suggests
THURSDAY, Sept. 22 (HealthDay News) -- People with type 2 diabetes taking the drugs Januvia or Byetta might have an increased risk of developing pancreatitis and pancreatic cancer, a preliminary study suggests. The study also found that Byetta (ex...
Sutent Approved for Rare Pancreatic Cancer
MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body. Neuroe...
Afinitor Approved for Rare Pancreatic Cancer
FRIDAY, May 6 (HealthDay News) -- U.S. Food and Drug Administration approval of Afinitor (everolimus) has been expanded to include people with progressive neuroendocrine tumors of the pancreas (PNET) that have spread to other parts of the body or ...
Monthly Aspirin Use Linked to Lower Pancreatic Cancer Risk
MONDAY, April 4 (HealthDay News) -- Taking aspirin even once per month, whether low-dose or full strength, appears to be associated with a marked drop in the risk of developing pancreatic cancer, new research reveals. Specifically, taking full-str...
Novel Treatment for Pancreatic Cancer Under Study
THURSDAY, March 24 (HealthDay News) -- Researchers appear to have found a new way to significantly shrink pancreatic tumors by targeting the tissue surrounding cancer rather than the cancer itself. The approach relies on an experimental antibody t...
Pancreatic Cancer Surprisingly Slow to Arise: Study
WEDNESDAY, Oct. 27 (HealthDay News) -- Pancreatic cancer takes much longer to develop than commonly thought, say researchers who found a lag time of at least a decade between the emergence of key mutations and the formation of the first cancer cel...
Soft Drinks Could Boost Pancreatic Cancer Risk
MONDAY, Feb. 8 (HealthDay News) -- People who down two or more soft drinks a week may have double the risk of developing deadly pancreatic cancer, compared to non-soda drinkers, new research suggests. But the overall number of people developing th...
Discovery Links Genes to Pancreatic Cancer
MONDAY, Jan. 25 (HealthDay News) -- Researchers have identified four regions of the human genome that predict a heightened risk of pancreatic cancer as a result of what they describe as the biggest-ever sweep of the genome for genes related to the...
New Test Catches Most Pancreatic Cancers Early
THURSDAY, Jan. 21 (HealthDay News) -- Researchers report they've developed a test that detects early-stage pancreatic cancer by measuring levels of a protein that's present in 90 percent of cancerous and precancerous lesions. "Most patients with p...
Stem Cells Being Tested to Fight Pancreatic Cancer
WEDNESDAY, Oct. 14 (HealthDay News) -- New research is moving scientists closer to their goal of treating pancreatic cancer by killing tumors without hurting healthy tissue. The researchers, who were scheduled to report their findings at the Ameri...
New Hope for Treatment of Pancreatic Cancer
FRIDAY, Sept. 25 (HealthDay News) -- Inhibiting the action of an enzyme called TAK-1 reverses pancreatic cancer resistance to chemotherapy, a finding that could lead to the development of a new way to treat the disease, researchers say. Pancreatic...
Pancreatic Cancer Deaths Higher for Blacks
WEDNESDAY, Sept. 2 (HealthDay News) -- Blacks have a significantly higher risk of dying from pancreatic cancer than whites, a new U.S. study has found. Even after eliminating known pancreatic cancer risk factors, such as smoking and obesity, black...
Blood Test May Spot Pancreatic Cancer Early
TUESDAY, Sept. 1 (HealthDay News) -- Texas scientists say they have found small molecules in the blood that can spot pancreatic cancer, a finding that could have diagnostic implications in the future. Levels of these molecules, called microRNAs, a...
Zenpep Approved for Pancreatic Disorder
FRIDAY, Aug. 28 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zenpep (pancrelipase) delayed-release capsules to treat a pancreatic disorder that prevents people from properly digesting food, Dutch drug maker Eurand NV said...
Blood Flow Mismatch Seen in Pancreatic Cancers
WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emiss...
Abnormal Protein May Signal Pancreatic Cancer
TUESDAY, Aug. 18 (HealthDay News) -- Prion, an abnormal protein, is a biomarker of early pancreatic cancer, a new study suggests. Prion accumulation causes mad cow disease, but very little is known about prions outside of the brain. This study ide...
Metformin May Lower Diabetics' Odds for Pancreatic Cancer
SUNDAY, Aug. 2 (HealthDay News) -- Metformin, one of the most widely used diabetes drugs, may offer patients the added benefit of lowering their odds for pancreatic cancer by 60 percent, a new study shows. But the study had a downside: Other commo...
Blood Type May Boost Pancreatic Cancer Risk
MONDAY, Aug. 3 (HealthDay News) -- Common variants of a gene that determines blood type are associated with an increased risk of pancreatic cancer, according to U.S. researchers. They studied the genomes of more than 4,300 pancreatic cancer patien...
Eating Animal Fat May Lead to Pancreatic Cancer
FRIDAY, June 26 (HealthDay News) -- Fat from red meat and dairy products can increase your risk for pancreatic cancer, researchers from the U.S. National Cancer Institute report. Pancreatic cancer, which is usually fatal, is the fourth-leading cau...
Obesity While Young Boosts Pancreatic Cancer Risk
TUESDAY, June 23 (HealthDay News) -- Being overweight or obese as a young adult increases the risk for pancreatic cancer, and obesity in middle age is linked with poorer survival from the disease, a new study finds. Pancreatic cancer is the fourth...
Simple Test Could Detect More Gastrointestinal Cancers
TUESDAY, June 2 (HealthDay News) -- DNA testing of a person's stool can accurately screen for more types of cancer than previously thought, a new study has found. While DNA stool testing has been successfully used for early detection of colorectal...
Avastin Shows No Benefit Against Early Stage Colon Cancer
SATURDAY, May 30 (HealthDay News) -- The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial's lead author called "disappointing." ...
Charring Meat May Boost Risk of Pancreatic Cancer
TUESDAY, April 21 (HealthDay News) -- You may love your steak well done, but eating burned or charred meat may increase your risk of pancreatic cancer, a new study suggests. Researchers used data on the meat intake, preferred cooking methods and d...
Research Takes Aim at Pancreatic Cancer
SATURDAY, April 18 (HealthDay News) -- An active receptor found in certain pancreatic cancers might offer hope for treatment of the often fatal disease. A third of human pancreatic cancers looked at by Johns Hopkins University researchers containe...
New Drug Being Tested for Pancreatic Cancer
WEDNESDAY, April 15 (HealthDay News) -- An experimental drug appeared to reduce pancreatic cancer growth in laboratory tests, according to researchers from the drug's maker, Amgen. Called AMG 479, the drug is designed to inhibit the activity of in...
Obesity Tied to Poor Pancreatic Cancer Surgery Outcomes
WEDNESDAY, March 18 (HealthDay News) -- Obese pancreatic cancer patients are more likely than non-obese patients to have worse outcomes after surgery to treat their cancer, say U.S. researchers. "We identified a subset of obese patients (BMI great...
Study Links Blood Type and Pancreatic Cancer
TUESDAY, March 10 (HealthDay News) --- People with type O blood have a much lower risk of developing pancreatic cancer, a finding that might help explain the origins of the often fatal disease. The study, by researchers at the Dana-Farber Cancer I...
Supreme Court Justice Ginsburg Faces Tough Battle Against Pancreatic Cancer
FRIDAY, Feb. 6 (HealthDay News) -- U.S. Supreme Court Justice Ruth Bader Ginsburg will face tough challenges following her surgery on Thursday for early-stage pancreatic cancer, experts say. At this point, it's not clear exactly what type of pancr...
Healthline Tools
3D Body Maps
Advertisement
Copyright © 2005 - 2012 Healthline Networks, Inc. All rights reserved.
Healthline is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations. more details